ZK283197

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZK283197, covering 2015-04-09 to 2015-04-09. Get the full timeline:

Most recent: Clinical Trial Update: ZK283197 for Treatment of Vasomotor Symptoms [Phase 2]